NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAMS E-216-2010-0-US-06 Compositions and Methods for Treating or Preventing Lupus US National Stage 13/989,744 9657292 Issued PDF
NCI E-243-2002-1-US-08 Recombinant Vaccine Viruses Expressing IL-15 and Methods of Using the Same US DIV 14/156,105 Abandoned
NICHD E-003-2014-0-US-01 Cartilage Targeting Agents And Their Use US 61/927,904 Abandoned
NCI E-003-2007-0-AU-16 Engineered Antibody Constant Domain Molecules AU DIV 2014200215 Issued
NIA E-089-2009-0-US-04 SPANX-B POLYPEPTIDES AND THEIR USE US DIV 14/155,230 9238684 Issued PDF
NIAID E-010-2014-0-US-01 MALARIA TRANSMISSION BLOCKING VACCINES US 61/927,166 Abandoned
NIDCR E-087-2011-0-US-04 AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome US National Stage 14/111,604 Abandoned
NCI E-295-2012-0-US-01 Anti-Viral Cnidarins US 61/925,347 Abandoned
NCI E-205-2010-2-SG-07 Photosensitizing Antibody-Flurophore Conjugates SG National Stage 201309182-2 Issued
NCI E-141-2008-0-JP-16 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof JP DIV 2014-001373 Abandoned
NHLBI E-758-2013-0-US-01 Antibody Targeting Cell Surface Deposited Complement Protein C3d and Use Thereof US 61/924,967 Abandoned
NCI E-062-2014-0-US-01 RAS Pathways As Markers Of Protection Against HIV And Means To Improve Vaccine Efficacy US 61/925,154 Abandoned
CC E-063-2011-0-US-03 Radiographic Marker That Displays An Angle In Degrees On Portable X-Rays US National Stage 14/005,024 9541822 Issued PDF
NCI E-254-2005-2-JP-19 CODON OPTIMIZED IL-15 AND IL-15R-ALPHA GENE EXPRESSION IN MAMMALIAN CELLS JP DIV 2014-000118 Issued
NHLBI E-183-2004-1-JP-09 COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISORDERS JP DIV 2014-000536 Abandoned
NIAID E-043-2014-0-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US 61/923,546 Abandoned
NIDCR E-308-2003-3-US-03 METHODS OF DIAGNOSING AND TREATING HYPERPROLIFERATIVE DISORDERS US CON 14/146,387 Abandoned
NHGRI E-324-2001-0-US-05 METHODS FOR ANALYZING HIGH DIMENSIONAL DATA FOR CLASSIFYING DIAGNOSING PROGNOSTICATING AND/OR PREDICTING DISEASES AND OTHER BIOLOGICAL STATES US CON 14/143,572 Abandoned
NIA E-088-2007-1-US-09 METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION US CON 14/143,568 Abandoned
NIAID E-050-1997-1-US-20 Method Of Sampling, Amplifying And Quantifying Segment Of Nucleic Acid US CON 14/142,488 Abandoned
NIAID E-531-2013-1-US-01 NOVEL EPSTEIN-BARR VIRUS VACCINES US 61/921,284 Abandoned
NCATS E-043-2013-0-PCT-02 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof PCT PCT PCT/US2013/077804 Expired
NCATS E-043-2013-0-EP-05 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof EP National Stage 13821618.9 Abandoned
NCATS E-043-2013-0-CA-04 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof CA National Stage 2896731 Abandoned
NCATS E-043-2013-0-AU-03 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof AU National Stage 2013370417 Abandoned
NCI E-074-2007-0-US-13 Brachyury Polypeptides and Methods for Use US CON 14/138,629 Abandoned
NINDS E-143-2002-0-US-13 Zenapax (Humanized Antibody Against the IL-2 Receptor Alpha Chain) As A Novel Treatment for Multiple Sclerosis US CON 14/139,424 Abandoned
NHLBI E-241-2010-0-US-04 CAPSID-FREE AAV VECTORS, COMPOSITIONS, AND METHODS FOR VECTOR PRODUCTION AND GENE DELIVERY US National Stage 14/004,379 9598703 Issued PDF
NIAID E-232-2004-4-US-10 Compositions And Methods For Generating An Immune Response US DIV 14/137,095 9254319 Expired PDF
NCI E-312-2005-0-US-05 Immunogenic Peptides and Methods of Use for Treating and Preventing Cancer US DIV 14/136,124 9206245 Abandoned PDF
NCI E-549-2013-0-US-01 IMMUNOGENIC JC POLYOMAVIRUS COMPOSITIONS AND METHODS OF USE US 61/919,043 Abandoned
NEI E-089-2011-0-US-01 Conjugates For Treating Inflammatory Disease and Identification of Patients Likely to Benefit from such Treatment US 61/919,404 Abandoned
NIAID E-124-2009-0-MX-14 Influenza Hemagglutinin And Neuraminidase Variants MX DIV MX/a/2013/015094 Abandoned
NICHD E-061-2005-0-US-05 A Novel Marker For Cardiomyocyte Progenitor Cells US CON 14/107,235 Abandoned
NCI E-050-2014-0-US-01 Cancer Immunotherapy By Delivering Class II MHC Antigens Using a VLP Replicon US 61/916,394 Abandoned
NCI E-059-2007-2-US-07 GP100-Specific T Cell Receptors and Related Materials and Methods of Use US DIV 14/106,031 9522948 Abandoned PDF
NCI E-205-2010-2-US-08 PHOTOSENSITIZING ANTIBODY - FLUOROPHORE CONJUGATES US National Stage 14/126,060 9358306 Issued PDF
NCI E-024-2011-0-US-07 TEM8 ANTIBODIES, CONJUGATES THEREOF, AND THEIR USE US National Stage 14/126,372 9181340 Issued PDF
NCI E-047-2014-0-US-01 Multi-Epitope TARP Peptide Vaccine And Uses Thereof US 61/915,948 Abandoned
NIAID E-067-2012-0-PCT-02 HIV THERAPEUTICS AND METHODS OF MAKING AND USING SAME PCT PCT PCT/US2013/074801 Expired
NIAID E-145-2011-0-CN-04 Plasmodial Surface Anion Channel Inhibitors For The Treatment Or Prevention Of Malaria CN National Stage 201280028801.8 Issued
NCI E-246-2003-1-US-11 NON-PEPTIDE AGONISTS AND ANTAGONISTS OF ADRENOMEDULLIN AND GASTRIN RELEASING PEPTIDE US DIV 14/103,605 Abandoned
NCI E-159-2011-2-US-06 CHALCONE DERIVATIVES AS NRF2 ACTIVATORS US National Stage 14/000,816 Abandoned
NIA E-059-2006-0-AU-09 METHOD OF TREATING OR PREVENTING OXIDATIVE STRESS-RELATED DISEASE AU DIV 2013267082 Abandoned
NCATS E-010-2013-0-EP-04 Sensor And Device For Real Time Detection Of Plasma Metabolites EP National Stage 13846569.5 Issued
NCI E-008-2014-0-US-01 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same US 61/912,948 Abandoned
NCI E-117-2011-0-MA-32 Recombinant Immunotoxin Targeting Mesothelin MA National Stage 36534 Abandoned
NCI E-148-2011-0-CN-05 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CN National Stage 201280027682.4 Issued
NCI E-174-2011-0-US-13 Pseudomonas Exotoxin A with Less Immunogenic T Cell and/or B Cell Epitopes US National Stage 14/123,971 9346859 Issued PDF
NIAID E-242-2014-0-US-01 A Monoclonal Antibody Against The N-terminal Portion Of The Circumsporozoite Protein Of Plasmodium Falciparum US ORD 14/097,799 9321834 Issued PDF